Characterization of anti-CCL28 as a novel therapy to overcome sorafenib resistance in HCC

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Characterization of anti-CCL28 as a novel therapy to overcome sorafenib resistance in HCC
Principal Investigator
Professor Ng, Irene Oi Lin   (Principal Investigator)
Duration
24
Start Date
2016-05-01
Amount
1173296
Conference Title
Characterization of anti-CCL28 as a novel therapy to overcome sorafenib resistance in HCC
Presentation Title
Keywords
CCL28, HCC, Patient-derived tumor, Regulatory T cells, Sorafenib
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
03142966
Grant Type
Health and Medical Research Fund - Full Grant
Funding Year
2015
Status
Completed
Objectives
Please refer to hard copy